This pilot project addresses health inequity in Kampala’s poorest slum by exploring the potential of increasing community-generated research findings.
HEPS Uganda Deputy ED, Denis Kibira and Programme Officer for Advocacy and Networking, Kenneth Mwehonge last week attended Aids Vaccine Advocacy Coalition Fellowship in Johannesburg, South Africa.
The HIV Prevention Research Advocacy Fellowship pairs emerging leaders in advocacy and activism with existing organizations to develop and execute creative, context-specific projects focused on HIV prevention research.
Fellowship projects focus primarily on advocacy around biomedical HIV prevention research (such as clinical trials of vaccines, microbicides, pre-exposure prophylaxis) or rollout of male circumcision for HIV prevention. Fellowship projects may also focus on “test and treat” or ARV treatment as prevention strategies, which are under active discussion in many contexts. Fellows receive training, financial support, and technical assistance to plan and implement a targeted one-year project within host organizations focused on HIV/AIDS.
This financial year, the Government has allocated an additional sh49.5b to the health ministry. Of this, sh6.5b has been availed immediately to kick-start the recruitment of over 6,000 health workers in health centres III, IV and V. Vicky Wandawa explores the likely impact of this
HEPS-Uganda is an acronym for Coalition for Health Promotion and Social Development.
It is a health rights organisation that advocates for increased access to affordable essential medicines for the poor and vulnerable people in Uganda.